Same Indication

Methotrexate vs Tildrakizumab

Methotrexate vs Tildrakizumab: Overview

This comparison examines the pharmacological differences between Methotrexate and Tildrakizumab.

Mechanism of Action

Methotrexate: Dihydrofolate reductase inhibitor.

Pharmacokinetics

Half-life: Methotrexate β€” 3-10 hours.

Chemical Properties

Molecular Formula: Methotrexate β€” C20H22N8O5.

Molecular Weight: Methotrexate β€” 454.4400 g/mol.

Type: Methotrexate β€” Small molecule; Tildrakizumab β€” Antibody.